EUVIMEDEUVIMED entdecken
Crossref

Peroxiredoxin 6 Protects Pulmonary Epithelial Cells From Cigarette-related Ferroptosis in Chronic Obstructive Pulmonary Disease

Tingting Wei, Xiaocen Wang, Ke Lang, Yansha Song, Jinlong Luo, Zhaolin Gu, Dong Yang, Yuanlin Song

Inflammation · 2024

DOI: 10.1007/s10753-024-02077-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, 2024. Verfasst von Tingting Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, PR China. Hauptthemen laut MEDLINE: Ferroptosis, Pulmonary Disease, Chronic Obstructive, Peroxiredoxin VI, Epithelial Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peroxiredoxin 6 (PRDX6) has a protective effect on pulmonary epithelial cells against cigarette smoke (CS)-induced ferroptosis. This study investigates the role of PRDX6 in the development of chronic obstructive pulmonary disease (COPD) and its possibility as a target. We observed that PRDX6 was downregulated in lung tissues of COPD patients and in CS-stimulated cells. The degradation of PRDX6 could be through the lysosomal pathway. PRDX6 deficiency exacerbated pulmonary inflammation and mucus hypersecretion in vivo. Overexpression of PRDX6 in Beas-2B cells ameliorated CS-induced cell death and inflammation, suggesting its protective role against CS-induced damage. Furthermore, PRDX6 deficiency promoted ferroptosis by adding the content of iron and reactive oxygen species, while iron chelation with deferoxamine mitigated CS-induced ferroptosis, cell death, and inflammatory infiltration both in vitro and in vivo. The critical role of PRDX6 in regulating ferroptosis suggests that targeting PRDX6 or iron metabolism may represent a promising strategy for COPD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisPulmonary Disease, Chronic ObstructivePeroxiredoxin VIEpithelial CellsLungCigarette SmokingHumansAnimalsMiceReactive Oxygen SpeciesCell Line

Stichwörter der Autor:innen

chronic obstructive pulmonary diseaseferroptosisheme oxygenase-1iron overloadoxidative stressperoxiredoxin 6

Substanzen

Peroxiredoxin VIPRDX6 protein, humanReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, PR China.
  • Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, PR China. yang.dong@zs-hospital.sh.cn.
  • Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, People's Republic of China. yang.dong@zs-hospital.sh.cn.
  • Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, People's Republic of China.

Zitieren

APA

Wei, T., Wang, X., Lang, K., Song, Y., Luo, J., Gu, Z., Yang, D., & Song, Y. (2024). Peroxiredoxin 6 Protects Pulmonary Epithelial Cells From Cigarette-related Ferroptosis in Chronic Obstructive Pulmonary Disease. Inflammation. https://doi.org/10.1007/s10753-024-02077-4

Vancouver

Wei T, Wang X, Lang K, Song Y, Luo J, Gu Z, et al. Peroxiredoxin 6 Protects Pulmonary Epithelial Cells From Cigarette-related Ferroptosis in Chronic Obstructive Pulmonary Disease. Inflammation. 2024. doi:10.1007/s10753-024-02077-4

BibTeX
@article{Wei2024,
  author = {Wei, Tingting and Wang, Xiaocen and Lang, Ke and Song, Yansha and Luo, Jinlong and Gu, Zhaolin and Yang, Dong and Song, Yuanlin},
  title = {Peroxiredoxin 6 Protects Pulmonary Epithelial Cells From Cigarette-related Ferroptosis in Chronic Obstructive Pulmonary Disease},
  journal = {Inflammation},
  year = {2024},
  doi = {10.1007/s10753-024-02077-4}
}
Kostenlos starten →